• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 422395 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416623758 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416623758 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Isis Pharmaceuticals, Up 2.1%

Published on Tue, 01/15/2013 - 13:17
By Peter Chu

One of today's stocks on the move is Isis Pharmaceuticals (NASDAQ:ISIS), up 2.1% to $13.98. The Dow Jones Industrial Average is now trading fractionally lower to 13,504 and the S&P is trading fractionally lower to 1,470.

Isis Pharmaceuticals (NASDAQ:ISIS) is currently priced 23.1% above its average consensus analyst price target of $10.75. The stock should find initial support at its 200-day moving average (MA) of $10.92 and further support at its 50-day MA of $9.68.

In the past 52 weeks, Isis Pharmaceuticals share prices have been bracketed by a low of $6.25 and a high of $15.61 and are now at $13.98, 124% above that low price. The 200-day and 50-day moving averages have moved 0.64% higher and 2.92% higher over the past week, respectively.

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Whirlpool: 52-Week High Recently Eclipse...

Whirlpool (NYSE:WHR) traded at a new 52-week high today of $185.34. This new high was ...

Watch for Continued Gains in Shares of W...

Werner Enterprises (NASDAQ:WERN) traded at a new 52-week high today of $29.10. So far ...

Watch for Continued Gains in Shares of W...

Shares of Waters (NYSE:WAT) traded today at $117.71, breaking its 52-week high. This n ...

Wabtec: The Winning Streak Continues (WA...

Wabtec (NYSE:WAB) traded today at a new 52-week high of $90.98. Approximately 327,000 ...

Recent 52-Week High Exceeded in Shares o...

Verint Systems (NASDAQ:VRNT) traded at a new 52-week high today of $60.25. Approximate ...

Validus Holdings: The Winning Streak Con...

Validus Holdings (NYSE:VR) traded at a new 52-week high today of $41.28. This new high ...

Meridian Bioscience Looks to Continue to...

Shares of Meridian Bioscience (NASDAQ:VIVO) traded today at $15.80, breaking its 52-wee ...

Shares of VF Corp Have Risen Above Previ...

Shares of VF Corp (NYSE:VFC) traded today at $74.35, breaking its 52-week high. This n ...